Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release titled "Solara is pleased to announce the successful closure of US FDA inspection of its Mangalore Facility with continued state of compliance on cGMP".
Press Release Nov 19 2025
Filed with NSE · · 2 pages · English
Release
Solara Active Pharma Sciences Ltd. on 6ix
Earlier from Solara Active Pharma Sciences
- Press Release Nov 05 2025
- Press Release Jul 25 2025
- Press Release May 15 2025
- Press Release May 10 2025
- Press Release Jan 24 2025
Later from Solara Active Pharma Sciences
- Press Release Feb 06 2026
- Press Release Apr 28 2026
- Press Release May 15 2026
- Solara Active Pharma Sciences Ltd. Press Release Jul 23 2026
- Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated October 16, 2026, titled "Solara s Q2 FY27 revenue grows 33% to INR 4,178 Mn and EBITDA more than doubles to INR 769 Mn, its best quarter in five years".
Follow Solara Active Pharma Sciences into a list and get an email when it puts out news.
Follow Solara Active Pharma Sciences